← Back to Search

Positive affect imagery for Sedentary Lifestyle

N/A
Waitlist Available
Led By Austin S. Baldwin, PhD
Research Sponsored by Southern Methodist University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not currently meeting physical activity guidelines (<150 minutes/week of self-reported moderate-to-vigorous physical activity)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed weekly at weeks 1-6
Awards & highlights

Study Summary

This trial is testing a new audio-recorded physical activity intervention to see which combination of components is most effective in increasing physical activity, while also minimizing participant burden.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are not currently exercising enough, which means you don't meet the recommended guidelines of moderate-to-vigorous physical activity for at least 150 minutes per week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed weekly at weeks 1-6
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed weekly at weeks 1-6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Weekly Physical Activity Minutes Across 6 Weeks (accelerometer-assessed)
Secondary outcome measures
Change in Weekly Physical Activity Minutes Across 6 Weeks (self-reported)
Other outcome measures
Action Planning
Affective Response to Exercise
Delayed Discounting
+2 more

Trial Design

16Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment4 Interventions
1) Episodic future thinking; 2) Neutral imagery; 3) Action planning; 4) High intervention dose
Group II: Condition 8Experimental Treatment3 Interventions
1) Recent thinking; 2) Positive affect imagery; 3) Low intervention dose
Group III: Condition 7Experimental Treatment3 Interventions
1) Recent thinking; 2) Positive affect imagery; 3) High intervention dose
Group IV: Condition 6Experimental Treatment4 Interventions
1) Recent thinking; 2) Positive affect imagery; 3) Action planning; 4) Low intervention dose
Group V: Condition 5Experimental Treatment4 Interventions
1) Recent thinking; 2) Positive affect imagery; 3) Action planning; 4) High intervention dose
Group VI: Condition 4Experimental Treatment3 Interventions
1) Episodic future thinking; 2) Positive affect imagery; 3) Low intervention dose
Group VII: Condition 3Experimental Treatment3 Interventions
1) Episodic future thinking; 2) Positive affect imagery; 3) High intervention dose
Group VIII: Condition 2Experimental Treatment4 Interventions
1) Episodic future thinking; 2) Positive affect imagery; 3) Action planning; 4) Low intervention dose
Group IX: Condition 16Experimental Treatment3 Interventions
1) Recent thinking; 2) Neutral imagery; 3) Low intervention dose
Group X: Condition 15Experimental Treatment3 Interventions
1) Recent thinking; 2) Neutral imagery; 3) High intervention dose
Group XI: Condition 14Experimental Treatment4 Interventions
1) Recent thinking; 2) Neutral imagery; 3) Action planning; 4) Low intervention dose
Group XII: Condition 13Experimental Treatment4 Interventions
1) Recent thinking; 2) Neutral imagery; 3) Action planning; 4) High intervention dose
Group XIII: Condition 12Experimental Treatment3 Interventions
1) Episodic future thinking; 2) Neutral imagery; 3) Low intervention dose
Group XIV: Condition 11Experimental Treatment3 Interventions
1) Episodic future thinking; 2) Neutral imagery; 3) High intervention dose
Group XV: Condition 10Experimental Treatment4 Interventions
1) Episodic future thinking; 2) Neutral imagery; 3) Action planning; 4) Low intervention dose
Group XVI: Condition 1Experimental Treatment4 Interventions
1) Episodic future thinking; 2) Positive affect imagery; 3) Action planning; 4) High intervention dose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High dose
2016
Completed Phase 2
~300
Episodic future thinking
2019
Completed Phase 2
~150
Low dose
2016
Completed Phase 4
~470
Action planning
2017
Completed Phase 2
~1610

Find a Location

Who is running the clinical trial?

Southern Methodist UniversityLead Sponsor
33 Previous Clinical Trials
5,681 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,607 Previous Clinical Trials
40,913,970 Total Patients Enrolled
5 Trials studying Sedentary Lifestyle
173 Patients Enrolled for Sedentary Lifestyle
University of Kansas Medical CenterOTHER
458 Previous Clinical Trials
168,896 Total Patients Enrolled
1 Trials studying Sedentary Lifestyle
64 Patients Enrolled for Sedentary Lifestyle

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many patients have been accepted into this clinical trial so far?

"Indeed, the information hosted on clinicaltrials.gov states that this medical study is recruiting participants at present. Initially posted on February 14th 2022, it was most recently altered on February 24th 2022 and aims to enrol 192 individuals from one site."

Answered by AI

Is enrollment for this research trial still available?

"Per the data available on clinicaltrials.gov, this experiment is actively searching for volunteers and was initially posted in February 14th 2022 with subsequent updates made on the 24th of that same month."

Answered by AI

Are there specific criteria for enrolling in this research program?

"This experiment is looking for 192 willing participants between the age of 18 and 64 that are physically inactive. Subjects need to have the capacity to give informed consent, be proficient in English, possess a smartphone with an active data plan, and not meet current physical activity standards (<150 minutes/week). Additionally, they must attend all study meetings as well as adhere to the protocol guidelines."

Answered by AI

Is this experiment open to participants younger than thirty years old?

"According to the study's prerequisites, only individuals aged 18-64 are eligible for inclusion."

Answered by AI
~62 spots leftby Mar 2025